Research Articles | Page 22 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Dec 2020 Blood, cells, molecules & diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes Apr 2019 Blood Reviews Myelodysplastic Syndromes (MDS)
Current and emerging strategies for management of myelodysplastic syndromes Dec 2020 Blood reviews Myelodysplastic Syndromes (MDS)
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age May 2023 Blood Reviews Myelodysplastic Syndromes (MDS)
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review Jul 2023 Blood Reviews Myelodysplastic Syndromes (MDS)
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Mar 2021 Blood cells, molecules and diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome Apr 2023 Blood Cancer Myelodysplastic Syndromes (MDS)
Towards a Conceptualization of Measurable Residual Disease in Myelodysplastic Syndromes Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies Oct 2023 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)